rs534723946

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015046.7(SETX):​c.1504C>T​(p.Arg502Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000258 in 1,614,192 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R502Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00029 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00025 ( 3 hom. )

Consequence

SETX
NM_015046.7 missense

Scores

4
8
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:6B:2

Conservation

PhyloP100: 1.97
Variant links:
Genes affected
SETX (HGNC:445): (senataxin) This gene encodes a protein named for its homology to the Sen1p protein of fungi which has RNA helicase activity encoded by a domain at the C-terminal end of the protein. The protein encoded by this gene contains a DNA/RNA helicase domain at its C-terminal end which suggests that it may be involved in both DNA and RNA processing. Mutations in this gene have been associated with ataxia-ocular apraxia-2 (AOA2) and an autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS4). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012727529).
BP6
Variant 9-132330094-G-A is Benign according to our data. Variant chr9-132330094-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 155742.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=4, Likely_benign=1, Benign=1}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000289 (44/152344) while in subpopulation SAS AF= 0.00621 (30/4830). AF 95% confidence interval is 0.00447. There are 1 homozygotes in gnomad4. There are 29 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SETXNM_015046.7 linkuse as main transcriptc.1504C>T p.Arg502Trp missense_variant 10/26 ENST00000224140.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SETXENST00000224140.6 linkuse as main transcriptc.1504C>T p.Arg502Trp missense_variant 10/261 NM_015046.7 P1Q7Z333-1

Frequencies

GnomAD3 genomes
AF:
0.000289
AC:
44
AN:
152226
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000769
Gnomad SAS
AF:
0.00621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000541
AC:
136
AN:
251320
Hom.:
0
AF XY:
0.000648
AC XY:
88
AN XY:
135830
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000652
Gnomad SAS exome
AF:
0.00353
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000704
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.000254
AC:
372
AN:
1461848
Hom.:
3
Cov.:
35
AF XY:
0.000326
AC XY:
237
AN XY:
727216
show subpopulations
Gnomad4 AFR exome
AF:
0.000119
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000151
Gnomad4 SAS exome
AF:
0.00306
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000683
Gnomad4 OTH exome
AF:
0.000331
GnomAD4 genome
AF:
0.000289
AC:
44
AN:
152344
Hom.:
1
Cov.:
33
AF XY:
0.000389
AC XY:
29
AN XY:
74500
show subpopulations
Gnomad4 AFR
AF:
0.0000962
Gnomad4 AMR
AF:
0.000261
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000771
Gnomad4 SAS
AF:
0.00621
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000880
Hom.:
0
Bravo
AF:
0.0000982
ExAC
AF:
0.000675
AC:
82
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:6Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:1Uncertain:2Benign:1
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The SETX p.Arg502Trp variant was identified in 2 of 310 proband chromosomes (frequency: 0.0065) from individuals with inherited peripheral neuropathies or amyotrophic lateral sclerosis (Drew_2015_PMID:25802885; Liu_2019_PMID:31788332). The variant was identified in dbSNP (ID: rs534723946) and ClinVar (classified as uncertain significance by the Inherited Neuropathy Consortium and Genomic Research Center, Shahid Beheshti University of Medical Sciences, and as probable-pathogenic by the Northcott Neuroscience Laboratory, ANZAC Research Institute). The variant was identified in control databases in 138 of 282726 chromosomes at a frequency of 0.0004881 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 108 of 30616 chromosomes (freq: 0.003528), Other in 5 of 7218 chromosomes (freq: 0.000693), East Asian in 12 of 19954 chromosomes (freq: 0.000601), African in 2 of 24966 chromosomes (freq: 0.00008), European (non-Finnish) in 9 of 129050 chromosomes (freq: 0.00007) and Latino in 2 of 35438 chromosomes (freq: 0.000056), but was not observed in the Ashkenazi Jewish, or European (Finnish) populations. The p.Arg502 residue is conserved across mammals and other organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Likely pathogenic, no assertion criteria providedliterature onlyNorthcott Neuroscience Laboratory, ANZAC Research Institute-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxApr 26, 2019See Variant Classification Assertion Criteria. -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicApr 17, 2020- -
Amyotrophic lateral sclerosis type 4 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingNeuberg Centre For Genomic Medicine, NCGM-The amino acid Arg at position 502 is changed to a Trp changing protein sequence and it might alter its composition and physico-chemical properties. This variant has been reported to the ClinVar database as Likely_pathogenic, however details are not available for independent assessment. The variant is predicted to be damaging by both SIFT and PolyPhen2. The residue is conserved across species. The amino acid change p.Arg502Trp in SETX is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain significance. -
Uncertain significance, criteria provided, single submitterclinical testingGenomic Research Center, Shahid Beheshti University of Medical SciencesApr 27, 2019- -
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria providedliterature onlyInherited Neuropathy Consortium-- -
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenomic Research Center, Shahid Beheshti University of Medical SciencesApr 27, 2019- -
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;C1865409:Amyotrophic lateral sclerosis type 4 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeSep 26, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
0.040
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.36
T
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.43
D
MetaRNN
Benign
0.013
T
MetaSVM
Uncertain
0.35
D
MutationAssessor
Benign
1.0
L
MutationTaster
Benign
0.80
D;D;D
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-2.4
N
REVEL
Pathogenic
0.80
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0080
D
Polyphen
1.0
D
Vest4
0.61
MutPred
0.43
Loss of disorder (P = 0.0273);
MVP
0.86
MPC
0.44
ClinPred
0.79
D
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.12
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs534723946; hg19: chr9-135205481; API